福瑞股份：内蒙古监管局对公司采取责令改正措施 并对相关责任人员出具警示函

Core Viewpoint - The company, Furuya Co., has received a decision from the Inner Mongolia Regulatory Bureau highlighting issues related to inadequate internal controls and improper revenue recognition for its overseas subsidiaries [1] Group 1: Internal Control Issues - The company lacks internal control and risk management systems for its overseas subsidiaries, leading to insufficient oversight and inspection by internal departments [1] - The regulatory decision indicates that the company's internal control mechanisms are not robust enough to manage the operations of its overseas entities [1] Group 2: Revenue Recognition Problems - The company recognizes revenue upon the shipment of pharmaceutical products, which has resulted in inaccuracies in financial disclosures across multiple periodic reports [1] - There is a failure to reasonably estimate sales discounts and other variable considerations, contributing to the misrepresentation of financial information [1] Group 3: Consequences for Management - The company's Chairman and General Manager, Wang Guan Yi, along with the Secretary of the Board and acting CFO, Sun Xiu Zhen, have received warning letters due to these issues [1]